Response of normal and colon cancer epithelial cells to TNF-family apoptotic inducers

Oncology Reports

Volumn 19, Issue 2, 2008, Pages 567-573

  Hofmanová, Jirina ^a   Vaculová, Alena ^a   Hyzd'Alová, Martina ^a   Kozubík, Alois ^a  

^a INSTITUTE OF MATHEMATICS   (Czech Republic)

Author keywords

Anti Fas; Apoptosis; Colon; TNF related apoptosis inducing ligand; TNF

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; CASPASE 9; CYCLOHEXIMIDE; DEATH RECEPTOR; DECOY RECEPTOR; FAS ANTIBODY; FLICE INHIBITORY PROTEIN; MITOCHONDRIAL PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN APO2.7; PROTEIN BCL 2; PROTEIN BID; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL POPULATION; CELL STRAIN HT29; COLON CANCER; COLON MUCOSA; CONTROLLED STUDY; DRUG POTENTIATION; DRUG RESPONSE; ENZYME ACTIVATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN SYNTHESIS;

EID: 38749129595     PISSN: 1021335X     EISSN: None     Source Type: Journal    
DOI: 10.3892/or.19.2.567     Document Type: Article

References (30)

1. Lifshitz S, Lamprecht SA, Benharroch D, Prinsloo I, Polak-Charcon S and Schwartz B: Apoptosis (programmed cell death) in colonic cells: from normal to transformed stage. Cancer Lett 163: 229-238, 2001.
2. Strater J and Moller P: Expression and function of death receptors and their natural ligands in the intestine. Ann NY Acad Sci 915: 162-170, 2000.
3. Manos EJ and Jones DA: Assessment of tumor necrosis factor receptor and Fas signaling pathways by transcriptional profiling. Cancer Res 61: 433-438, 2001.
4. MacFarlane M: TRAIL-induced signalling and apoptosis. Toxicol Lett 139: 89-97, 2003.
5. Ozoren N and El-Deiry WS: Defining characteristics of Types I and II apoptotic cells in response to TRAIL. Neoplasia 4: 551-557, 2002.
6. Sprick MR and Walczak H: The interplay between the Bcl-2 family and death receptor-mediated apoptosis. Biochim Biophys Acta 1644: 125-132, 2004.
7. Jaattela M: Biologic activities and mechanisms of action of TNF-alpha/ Cachektin. Biol Dis 64: 724-742, 1991.
8. Krammer PH, Galle PR, Moller P and Debatin KM: CD95 (APO-1/Fas)-mediated apoptosis in normal and malignant liver, colon, and hematopoietic cells. Adv Cancer Res 75: 251-273, 1998.
9. Velthuis JH, Rouschop KM, De Bont HJ, Mulder GJ and Nagelkerke JF: Distinct intracellular signaling in tumor necrosis factor-related apoptosis-inducing ligand- and CD95 ligand-mediated apoptosis. J Biol Chem 277: 24631-24637, 2002.
10. Fiorucci G, Vannucchi S, Chiantore MV, Percario ZA, Affabris E and Romeo G: TNF-related apoptosis-inducing ligand (TRAIL) as a pro-apoptotic signal transducer with cancer therapeutic potential. Curr Pharm Des 11: 933-944, 2005.
11. Hague A, Hicks DJ, Hasan F, Smartt H, Cohen GM, Paraskeva C and MacFarlane M: Increased sensitivity to TRAIL-induced apoptosis occurs during the adenoma to carcinoma transition of colorectal carcinogenesis. Br J Cancer 92: 736-742, 2005.
12. Van Geelen CM, de Vries EG and de Jong S: Lessons from TRAIL-resistance mechanisms in colorectal cancer cells: paving the road to patient-tailored therapy. Drug Resist Updat 7: 345-358, 2004.
13. Kim K, Fisher MJ, Xu SQ and el-Deiry WS: Molecular determinants of response to TRAIL in killing of normal and cancer cells. Clin Cancer Res 6: 335-346, 2000.
14. Hofmanova J, Vaculova A and Kozubik A: Polyunsaturated fatty acids sensitize human colon adenocarcinoma HT-29 cells to death receptor-mediated apoptosis. Cancer Lett 218: 33-41, 2005.
15. Vaculova A, Hofmanova J, Soucek K, Andera L and Kozubik A: Ethanol acts as a potent agent sensitizing colon cancer cells to the TRAIL-induced apoptosis. FEBS Lett 577: 309-313, 2004.
16. Kovarikova M, Pachernik J, Hofmanova J, Zadak Z and Kozubik A: TNF-alpha modulates the differentiation induced by butyrate in the HT-29 human colon adenocarcinoma cell line. Eur J Cancer 36: 1844-1852, 2000.
17. Vaculova A, Hofmanova J, Soucek K, Kovarikova M and Kozubik A: Tumor necrosis factor-alpha induces apoptosis associated with poly(ADP-ribose) polymerase cleavage in HT-29 colon cancer cells. Anticancer Res 22: 1635-1639, 2002.
18. Wilson CA and Browning JL: Death of HT29 adenocarcinoma cells induced by TNF family receptor activation is caspase-independent and displays features of both apoptosis and necrosis. Cell Death Differ 9: 1321-1333, 2002.
19. von Reyher U, Strater J, Kittstein W, Gschwendt M, Krammer PH and Moller P: Colon carcinoma cells use different mechanisms to escape CD95-mediated apoptosis. Cancer Res 58: 526-534, 1998.
20. Strater J and Moller P: CD95 (Fas/APO-1)/CD95L in the gastrointestinal tract: fictions and facts. Virchows Arch 442: 218-225, 2003.
21. Zhang XD, Nguyen T, Thomas WD, Sanders JE and Hersey P: Mechanisms of resistance of normal cells to TRAIL induced apoptosis vary between different cell types. FEBS Lett 482: 193-199, 2000.
22. Koornstra JJ, Jalving M, Rijcken FE, et al: Expression of tumour necrosis factor-related apoptosis-inducing ligand death receptors in sporadic and hereditary colorectal tumours: potential targets for apoptosis induction. Eur J Cancer 41: 1195-1202, 2005.
23. Jin Z, McDonald ER 3rd, Dicker DT and El-Deiry WS: Deficient tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) death receptor transport to the cell surface in human colon cancer cells selected for resistance to TRAIL-induced apoptosis. J Biol Chem 279: 35829-35839, 2004.
24. Muppidi JR, Tschopp J and Siegel RM: Life and death decisions: secondary complexes and lipid rafts in TNF receptor family signal transduction. Immunity 21: 461-465, 2004.
25. Ryu BK, Lee MG, Chi SG, Kim YW and Park JH: Increased expression of cFLIP(L) in colonic adenocarcinoma. J Pathol 194: 15-19, 2001.
26. Galligan L, Longley DB, McEwan M, Wilson TR, McLaughlin K and Johnston PG: Chemotherapy and TRAIL-mediated colon cancer cell death: the roles of p53, TRAIL receptors, and c-FLIP. Mol Cancer Ther 4: 2026-2036, 2005.
27. Lippa MS, Strockbine LD, Le TT, Branstetter DG, Strathdee CA and Holland PM: Expression of anti-apoptotic factors modulates Apo2L/TRAIL resistance in colon carcinoma cells. Apoptosis (In press).
28. van Geelen CM, de Vries EG, Le TK, van Weeghel RP and de Jong S: Differential modulation of the TRAIL receptors and the CD95 receptor in colon carcinoma cell lines. Br J Cancer 89: 363-373, 2003.
29. Vaculova A, Hofmanova J, Soucek K and Kozubik A: Different modulation of TRAIL-induced apoptosis by inhibition of prosurvival pathways in TRAIL-sensitive and TRAIL-resistant colon cancer cells. FEBS Lett 580: 6565-6569, 2006.
30. Zhang XD, Borrow JM, Zhang XY, Nguyen T and Hersey P: Activation of ERK1/ 2 protects melanoma cells from TRAIL-induced apoptosis by inhibiting Smac/DIABLO release from mitochondria. Oncogene 22: 2869-2881, 2003.